Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us
Conference Highlights
Connective Tissue Oncology Society (CTOS)
CTOS 2016
CTOS 2016
Trabectedin or Gemcitabine-Taxotere in Relapsed Uterine Leiomyosarcoma (U-LMS)
CTOS 2016
Read More ›
Phase 2 Study of Regorafenib in Patients with Metastatic STS (RESOUND)
CTOS 2016
Read More ›
Adjuvant Therapies in Major Histological Subtypes of Extremity Soft-Tissue Sarcoma (STS)
CTOS 2016
Read More ›
Alternate Dosing Regimen of Regorafenib in Gastrointestinal Stromal Tumors (GISTs)
CTOS 2016
Read More ›
Outcomes of Older Patients with Osteosarcoma from the French Group Sarcoma (GSF-GETO)
CTOS 2016
Read More ›
Trabectedin Approved for Use in Uterine Leiomyosarcoma
CTOS 2016
In this interview, Martee Hensley, MD, a medical oncologist practicing at Memorial Sloan Kettering Cancer Center, commented on the introduction of trabectedin as a treatment alternative for women with uterine leiomyosarcoma.
Read More ›
Page 2 of 2
1
2
Home
Conference Highlights
View All Conference Highlights
Year in Review / Wrap-Ups
Wrap-Ups
Year in Review
Contact Us